Bausch Health Co. Inc. (NYSE: BHC) reported Q4 EPS of $0.19, $1.22 worse than the analyst estimate of $1.41. Revenue for the quarter came in at $2.2 billion versus the consensus estimate of $2.79 billion.

GUIDANCE:

Bausch Health Co. Inc. sees 2022 revenue of $8.4-8.6 billion, may not compare versus the consensus of $11.22 billion.

• Full-year Adjusted EBITDA (non-GAAP)11 range of $3.45 – $3.60 billion

For earnings history and earnings-related data on Bausch Health Co. Inc. (BHC) click here.